Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

May 01, 1967; Volume 156,Issue 2

Articles

  • You have access
    A COMPARISON OF CERTAIN PROPERTIES OF CATECHOL-O-METHYL TRANSFERASE TO THOSE OF ADRENERGIC BETA RECEPTORS
    Ralph E. Giles and Jack W. Miller
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 201-206;
  • You have access
    AGONIST-ANTAGONIST INTERACTIONS IN THE NORMAL AND SUPERSENSITIVE NICTITATING MEMBRANE OF THE SPINAL CAT
    Richard D. Green and William W. Fleming
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 207-214;
  • You have access
    EFFECT OF SYMPATHECTOMY AND ADRENALECTOMY UPON GANGLION BLOCKADE
    Marshall Steinberg and James G. Hilton
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 215-220;
  • You have access
    MECHANISM OF THE VASODILATOR RESPONSE TO PHENIPRAZINE
    Shakil Mohammed, Harold F. Hardman and Albert C. Yard
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 221-226;
  • You have access
    THE STIMULATION OF CANINE PROSTATIC SECRETION BY SYMPATHOMIMETIC AMINES
    Emil R. Smith
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 227-231;
  • You have access
    INVESTIGATION OF SYMPATHETIC ACTIVITY RESULTING FROM A DOSE OF ACETYLCHOLINE PRODUCING A HYPERTENSIVE RESPONSE
    V. L. Carter, D. L. Traber and R. W. Gardier
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 232-237;
  • You have access
    STRUCTURE-ACTIVITY RELATIONSHIPS AMONG A SERIES OF ACETYLENIC CARBAMATES RELATED TO McN-A-343
    Adolph P. Roszkowski and John Yelnosky
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 238-245;
  • You have access
    QUANTITATIVE ASPECTS OF THE REPLACEMENT OF NOREPINEPHRINE BY DOPAMINE AS A SYMPATHETIC TRANSMITTER AFTER INHIBITION OF DOPAMINE-β-HYDROXYLASE BY DISULFIRAM
    H. Thoenen, W. Haefely, K. F. Gey and A. Huerlimann
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 246-251;
  • You have access
    STIMULATION OF THE CATECHOLAMINE OUTPUT OF THE ISOLATED, PERFUSED ADRENAL GLAND OF THE DOG BY ANGIOTENSIN AND BRADYKININ
    Robert L. Robinson
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 252-257;
  • You have access
    RELATIONSHIP BETWEEN HYPOTHALAMIC CATECHOLAMINES AND GONADOTROPHIN SECRETION IN RATS
    W. Lippmann, R. Leonardi, J. Ball and J. A. Coppola
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 258-266;
  • You have access
    RELEASE OF INTESTINAL 5-HYDROXYTRYPTAMINE BY MORPHINE AND RELATED AGENTS
    T. F. Burks and J. P. Long
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 267-276;
  • You have access
    INHIBITION OF GLUCONEOGENESIS BY HYDRAZINE ADMINISTRATION IN RATS
    Sidney R. Fortney, Dale A. Clark and Eduardo Stein
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 277-284;
  • You have access
    PHARMACOKINETICS OF SALICYLAMIDE ELIMINATION IN MAN
    Gerhard Levy and Tai Matsuzawa
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 285-293;
  • You have access
    THE EFFECT OF STRESS UPON THE PERFORMANCE OF THE AMINE-DEPLETED HEART
    C. R. Bariso, T. E. Gaffney, H. Fukusumi, J. Holmes, N. O. Fowler and E. C. Conradi
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 294-299;
  • You have access
    INFLUENCE OF OUABAIN ON THE FORMATION OF CORTICOSTERONE IN THE RAT ADRENAL GLAND
    Allen W. Gomoll
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 300-309;
  • You have access
    EFFECTS OF DOPAMINE AND α-METHYL-DOPAMINE ON SMOOTH MUSCLE AND ON THE CARDIAC PACEMAKER
    T. H. Tsai, S. Z. Langer and U. Trendelenburg
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 310-324;
  • You have access
    CARDIOVASCULAR AND MYOCARDIAL METABOLIC EFFECTS OF INFUSIONS OF PHENYLEPHRINE
    Philip J. Privitera and Ira Rosenblum
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 325-330;
  • You have access
    A COMPARISON OF THE ANTIARRHYTHMIC ACTIONS OF TWO NEW SYNTHETIC COMPOUNDS, IPROVERATRIL AND MJ 1999, WITH QUINIDINE AND PRONETHALOL
    Jack R. Schmid and Calvin Hanna
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 331-338;
  • You have access
    THE CARDIAC ACTION OF LYSOLECITHIN
    William C. Govier and Margaret C. Boadle
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 339-344;
  • You have access
    REACTIVATION BY PYRIDINIUM ALDOXIME METHOCHLORIDE (PAM) OF INHIBITED CHOLINESTERASE ACTIVITY IN DOGS AFTER POISONING WITH PINACOLYL METHYLPHOSPHONOFLUORIDATE (SOMAN)
    Joseph H. Fleisher, Larrel W. Harris and Edmund F. Murtha
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 345-351;
  • You have access
    MALATHION INHIBITION OF ESTERASES AS A DETERMINANT OF MALATHION TOXICITY
    Sheldon D. Murphy
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 352-365;
  • You have access
    CHLOROTHIAZIDE-INDUCED KALIURESIS AFTER ADRENALECTOMY
    Jay Y. Gillenwater and George D. Webster
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 366-368;
  • You have access
    THE USE OF A CLINICAL WHOLE-BODY COUNTER IN LONG-TERM EXCHANGEABLE SODIUM STUDIES FOR THE COMPARISON OF THE EFFECT OF DIFFERENT DIURETICS
    C. Constantinides, D. Binopoulos and B. Malamos
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 369-374;
  • You have access
    A METHOD FOR THE EVALUATION OF HYPNOTIC AGENTS IN MAN. THE COMPARATIVE HYPNOTIC EFFECTS OF SECOBARBITAL, METHAQUALONE AND A PLACEBO IN NORMAL SUBJECTS AND IN PSYCHIATRIC PATIENTS
    S. S. Bloomfield, L. Tetreault, B. Lafreniere and J. M. Bordeleau
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 375-382;
  • You have access
    THE ANTICONVULSANT ACTION OF INHIBITORS OF CARBONIC ANHYDRASE: SITE AND MODE OF ACTION IN RATS AND MICE
    William D. Gray and Charles E. Rauh
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 383-396;
  • You have access
    RELATION OF CHLORPROMAZINE-EVOKED HYPOTHERMIA TO DISRUPTION OF CONDITIONED AVOIDANCE-ESCAPE BEHAVIOR
    Thomas A. Rudy and Harold H. Wolf
    Journal of Pharmacology and Experimental Therapeutics May 1967, 156 (2) 397-406;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 156, Issue 2
1 May 1967
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Sign up for alerts

Jump to

  • Articles
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • SEP-363856, a Novel, Non-D2 Psychotropic Agent
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics